Home  /  Resource Library  /  Improvement of outcomes of an escalated high dose methotrexate based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real world cohort study

Improvement of outcomes of an escalated high dose methotrexate based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real world cohort study

Results of a real world study investigating high dose methotrexate for first line treatment of central nervous system lymphoma.